Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. [5]

Feb 21, 2025 · Urokinase is a thrombolytic (THROM-bo-LIT-ik) drug, sometimes called a "clot-busting" drug. It helps your body produce a substance that dissolves unwanted blood clots. Urokinase is used to treat blood clots in the lungs.

Aug 27, 2007 · Urokinase injection is used to dissolve blood clots that have formed in the lungs (pulmonary embolism). This medicine was available only with your doctor's prescription. This medicine is not available in the United States as of October 2010.

Jun 13, 2005 · Urokinase is a low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.

UROKINASE (yoor uh KAHY neys) breaks up blood clots. It is used to treat large blood clots formed in the lungs.

KinlyticTM (urokinase for injection) is a thrombolytic agent obtained from human neonatal kidney cells grown in tissue culture. The principal active ingredient of KinlyticTM is the low...

Urokinase is a serine protease that directly cleaves plasminogen to form active plasmin. It is used to treat occlusive venous and arterial disease and for occluded intravascular catheters and haemodialysis shunts.

Urokinase is a prescription medication used to treat blood clots in the lungs. Urokinase are available under various brand names: Abbokinase, Kinlytic

Oct 6, 2023 · Urokinase is a thrombolytic medication made from human neonatal kidney cells. Urokinase is an enzyme (protein) that disrupts the clotting cycle and breaks down blood clots lodged in the lungs in people with pulmonary embolism. The FDA approved urokinase under the brand name Kinlytic in 2007.

View urokinase information, including dose, uses, side-effects, renal impairment, pregnancy, breast feeding, contra-indications and directions for administration.